Showing results (121-130 of 273) with videos related to
Sort By:
Pageof 28
European Heart Journal|August 6, 2015
Optical coherence tomography imaging during percutaneous coronary intervention impacts physician decision-making: ILUMIEN I studyWilliam Wijns, Junya Shite, Michael R Jones, et al.The American Journal of Cardiology|December 1, 2006
Early- and medium-term outcomes after paclitaxel-eluting stent implantation for sirolimus-eluting stent failureSteve S Lee, Matthew J Price, Garrett B Wong, et al.American Heart Journal|April 21, 2009
Evaluation of individualized clopidogrel therapy after drug-eluting stent implantation in patients with high residual platelet reactivity: design and rationale of the GRAVITAS trialMatthew J Price, Peter B Berger, Dominick J Angiolillo, et al.Circulation. Cardiovascular Interventions|December 17, 2017
ACIST-FFR Study (Assessment of Catheter-Based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement)William F Fearon, Jeffrey W Chambers, Arnold H Seto, et al.Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 24, 2017
Safety and efficacy of the next generation Resolute Onyx zotarolimus-eluting stent: Primary outcome of the RESOLUTE ONYX core trialMatthew J Price, Richard A Shlofmitz, Douglas J Spriggs, et al.Circulation. Genomic and Precision Medicine|June 28, 2024
Invasive Assessment of Coronary Artery Disease in Clonal Hematopoiesis of Indeterminate PotentialJ Brett Heimlich, Michael A Raddatz, John Wells, et al.Journal of the American College of Cardiology|February 21, 2006
Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularizationMatthew J Price, Ecaterina Cristea, Neil Sawhney, et al.JACC. Heart Failure|April 28, 2023
No-Implant Interatrial Shunt for HFpEF: 6-Month Outcomes From Multicenter Pilot Feasibility StudiesJames E Udelson, Colin M Barker, Gerard Wilkins, et al.Circulation|August 31, 2011
Platelet reactivity and cardiovascular outcomes after percutaneous coronary intervention: a time-dependent analysis of the Gauging Responsiveness with a VerifyNow P2Y12 assay: Impact on Thrombosis and Safety (GRAVITAS) trialMatthew J Price, Dominick J Angiolillo, Paul S Teirstein, et al.JACC. Cardiovascular Interventions|July 22, 2017
First Report of the Resolute Onyx 2.0-mm Zotarolimus-Eluting Stent for the Treatment of Coronary Lesions With Very Small Reference Vessel DiameterMatthew J Price, Shigeru Saito, Richard A Shlofmitz, et al.Pageof 28